TrademarkDir
SUMITOMO DAINIPPON PHARMA ONCOLOGY
LIVE

Serial Number

79295713

Owner

Sumitomo Dainippon Pharma Co., Ltd.

Attorney

Rebeccah Gan

Filing Date

Jul 7, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SUMITOMO DAINIPPON PHARMA ONCOLOGY Trademark

Serial Number: 79295713 • Registration: 6367031

SUMITOMO DAINIPPON PHARMA ONCOLOGY is a trademark filed by Sumitomo Dainippon Pharma Co., Ltd. on July 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Sumitomo Dainippon Pharma Co., Ltd.

6-8, Doshomachi 2-chome,

Entity Type: 03

Trademark Details

Filing Date

July 7, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Anti-cancer preparations; pharmaceutical preparations for the diagnosis, prevention and treatment of cancer; biological preparations for the treatment of cancer

Providing medical information; providing information in the field of cancer prevention, screening, diagnosis and treatment; health care services for treating cancer

Testing, inspection or research of pharmaceuticals; testing, inspection or research of pharmaceuticals for the diagnosis, prevention and treatment of cancer

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 1, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2021 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 23, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2021 TEME
REFUSAL PROCESSED BY IB
Dec 7, 2020 RFNT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2020 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 28, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 24, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 19, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 15, 2020 REPR

Related Trademarks

More from this Owner

C THE CANSTEM TRIAL logo

C THE CANSTEM TRIAL

THE WIZARD TRIAL logo

THE WIZARD TRIAL

C THE CANSTEM TRIAL logo

C THE CANSTEM TRIAL

THE WIZARD TRIAL logo

THE WIZARD TRIAL

PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES logo

PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES

PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES logo

PRISM WORKING TOGETHER TOWARDS SCIENTIFIC ADVANCES